A carregar...

Beryllium competitively inhibits brain myo-inositol monophosphatase, but unlike lithium does not enhance agonist-induced inositol phosphate accumulation.

Despite limiting side-effects, lithium is the drug of choice for the treatment of bipolar depression. Its action may be due, in part, to its ability to dampen phosphatidylinositol turnover by inhibiting myo-inositol monophosphatase. Beryllium has been identified as a potent inhibitor of partially pu...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Faraci, W S, Zorn, S H, Bakker, A V, Jackson, E, Pratt, K
Formato: Artigo
Idioma:Inglês
Publicado em: 1993
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1132534/
https://ncbi.nlm.nih.gov/pubmed/8387266
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!